Zhang Z - Search Results

1

FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma.

Lyu N, Lin Y, Kong Y, Zhang Z, Liu L, Zheng L, Mu L, Wang J, Li X, Pan T, Xie Q, Liu Y, Lin A, Wu P, Zhao M. Lyu N, et al. Among authors: zhang z. Gut. 2018 Feb;67(2):395-396. doi: 10.1136/gutjnl-2017-314138. Epub 2017 Jun 7. Gut. 2018. PMID: 28592441 No abstract available.

2

[Comparison of enhanced thin CT sections with pathologic findings in pulmonary carcinoma, inflammatory, pseudo-tumor and pulmonary tuberculoma].

Zhang Z, Zhang C, Wu P, Ruan C, Zheng L, Zhang W, Li J, Wu Y, Cai P. Zhang Z, et al. Among authors: zhang c, zhang w. Zhonghua Zhong Liu Za Zhi. 2002 Mar;24(2):173-7. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12015042 Chinese.

3

Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis.

Chen J, Yao K, Li Z, Deng C, Wang L, Yu X, Liang P, Xie Q, Chen P, Qin Z, Ye Y, Liu Z, Zhou F, Zhang Z, Han H. Chen J, et al. Among authors: zhang z. Oncotarget. 2016 Aug 9;7(32):51687-51698. doi: 10.18632/oncotarget.10098. Oncotarget. 2016. PMID: 27351128 Free PMC article.

4

Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma.

Xie QK, Zhao YJ, Pan T, Lyu N, Mu LW, Li SL, Shi MD, Zhang ZF, Zhou PH, Zhao M. Xie QK, et al. Oncoimmunology. 2016 May 13;5(7):e1181252. doi: 10.1080/2162402X.2016.1181252. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622038 Free PMC article.

5

Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma.

Deng C, Li Z, Guo S, Chen P, Chen X, Zhou Q, Chen J, Yu X, Wu X, Ma W, Xie Q, Ye Y, Li Y, Qin Z, Liu Z, Liu R, Zhang Z, Yao K, Han H, Zhou F. Deng C, et al. Among authors: zhang z. Oncoimmunology. 2016 Dec 22;6(2):e1269047. doi: 10.1080/2162402X.2016.1269047. eCollection 2017. Oncoimmunology. 2016. PMID: 28344882 Free PMC article.

6

Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.

Lyu N, Kong Y, Mu L, Lin Y, Li J, Liu Y, Zhang Z, Zheng L, Deng H, Li S, Xie Q, Guo R, Shi M, Xu L, Cai X, Wu P, Zhao M. Lyu N, et al. Among authors: zhang z. J Hepatol. 2018 Jul;69(1):60-69. doi: 10.1016/j.jhep.2018.02.008. Epub 2018 Feb 20. J Hepatol. 2018. PMID: 29471013

7

Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma.

Deng H, Kan A, Lyu N, Mu L, Han Y, Liu L, Zhang Y, Duan Y, Liao S, Li S, Xie Q, Gao T, Li Y, Zhang Z, Zhao M. Deng H, et al. Among authors: zhang z, zhang y. Liver Cancer. 2020 Jun;9(3):338-357. doi: 10.1159/000505695. Epub 2020 Feb 25. Liver Cancer. 2020. PMID: 32647635 Free PMC article.

8

Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.

Deng H, Kan A, Lyu N, He M, Huang X, Qiao S, Li S, Lu W, Xie Q, Chen H, Lai J, Chen Q, Jiang X, Liu S, Zhang Z, Zhao M. Deng H, et al. Among authors: zhang z. J Immunother Cancer. 2021 Jun;9(6):e002305. doi: 10.1136/jitc-2020-002305. J Immunother Cancer. 2021. PMID: 34168004 Free PMC article.

9

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.

Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H, Huang Y, Wu Q, Li X, He B, Li T, Liang B, Zhang J, Cao B, Liu M, Feng Y, Ye X, Chen X, Wang L, Tian Y, Li H, Li J, Hu H, He J, Hu Y, Zhi C, Tang Z, Gong Y, Xu F, Xu L, Fan W, Zhao M, Chen D, Lian H, Yang L, Li P, Zhang Z. Pang N, et al. Among authors: zhang j, zhang z. J Hematol Oncol. 2021 Jul 29;14(1):118. doi: 10.1186/s13045-021-01128-9. J Hematol Oncol. 2021. PMID: 34325726 Free PMC article. Clinical Trial.

10

Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer.

Cao B, Liu M, Wang L, Zhu K, Cai M, Chen X, Feng Y, Yang S, Fu S, Zhi C, Ye X, Zhang J, Zhang Z, Yang X, Zhao M, Wu Q, Xu L, Yang L, Lian H, Zhao Q, Zhang Z. Cao B, et al. Among authors: zhang j, zhang z. Nat Commun. 2022 Oct 19;13(1):6203. doi: 10.1038/s41467-022-33968-5. Nat Commun. 2022. PMID: 36261437 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103,233 results

Search Page